Abstract C57: Observation of experimental and clinic curative effect on Z-C medicine treating malignancy
Conferences
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
Abstract• Objectives: To find traditional Chinese medicines of treating carcinoma which are good for curative effect and have no side effect.• Methods We use liver cancer H2,2 to inoculate 260 Kun Ming little white mice which are divided into group Z-C1 and group Z-C4, group of chemical treatment (CTX) and group of contrapose.• Results: We observe that the repression rate of mice H22 in liver cancer to of group Z-C1 for 2, 4, 6 weeks is 40%, 45% and 58%, and repression rate of mice H22 in liver cancer to of group Z-C4 for 2, 4, 6 weeks is 55%,68% and 70%, while repression rate of group CTX for 2, 4 and 6 weeks is 45%, 45% and 49%. For ten years' clinic abservation of 4277 middle and later period cancer patients, we find that Z-C medicine has good effect to prolong survival and has no side response for long time taking patients.• Conclusions: Through experimental research and clinic validation, it is proved that Z-C1, Z-C4 medicine can improve the survival quality and immunity of middle and later period patients, and control the increase of carcinoma cells to get a further curative effectCitation Format: Ze Xu, Jie Xu, Shiping Zhu, Shaoming Qio, Bin Wu. Observation of experimental and clinic curative effect on Z-C medicine treating malignancy. [abstract]. In: Proceedings of the Third AACR International Conference on Frontiers in Basic Cancer Research; Sep 18-22, 2013; National Harbor, MD. Philadelphia (PA): AACR; Cancer Res 2013;73(19 Suppl):Abstract nr C57.
